Fairvalue-Calculator Fairvalue-Calculator
EN DE

IRRA (IRRA) Fair Value & Analysis

Healthcare · ID · Market cap 501B IDR

Price368.00 IDR
Fair Value738.81 IDR
Upside+100.8%
Quality95/100
Evidence: Medium Range 554.11 IDR – 1,237 IDR

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

IRRA (IRRA) currently trades at 368.00 IDR, while our model-based Fair Value estimate is 738.81 IDR — implying the stock looks roughly 100.8% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

PT Itama Ranoraya Tbk wholesale trades in laboratory and pharmaceutical equipment, and medical devices for humans in Indonesia. It offers in vitro diagnostics products comprising rapid test, serology, glucose diagnostic, NAPZA test, and clinical laboratory; medical imaging products, including bone densitometer, C-arm, flat panel digital detector, mobile and stationary x-ray, and mammography; nefrology, blood and transfusion, orthopedic, radiotherapy, and surgical products; and hospital supplies and hospital kitchen equipment. The company also provides cold chain management, such as cold room, bloodbank, and pharmaceutical refrigerator; critical care; and pharmaceutical supplements, as well as maternal and neonatal care products. In addition, it leases office space. It sells its products under the oneject, Abbott, Terumo, DIRUI, Medtronic, mindray, ZOLL, Sansin, Vestfrost, ASCENSIA, Hemocue, CUREXO, SATInc., PT. MEGA, Planmed, Sinmed, Balmed, KSM CARE, Trisan Care, Shamrock, OTORO, G…

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) +24% Cencora, Inc (C1CO34) -44% Cardinal Health, Inc (CAH) -54% Sigma Healthcare Limited (SIGGF) -67% Sitka Gold Corp (SIG) -88% Shanghai Pharmaceuticals Holding (601607) +255%

Frequently asked questions

Is IRRA (IRRA) undervalued?
As of Jun 25, 2026, our model estimates a fair value of 738.81 IDR versus a price of 368.00 IDR — about +101% (undervalued). Model-based estimate, not financial advice.
What is the fair value of IRRA?
Our 21-model fair value for IRRA is 738.81 IDR (as of Jun 25, 2026), built from audited fundamentals. The current price is 368.00 IDR.
What is the quality score of IRRA?
IRRA has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.